Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality
This secondary analysis of a randomized clinical trial assesses whether screening for prostate-specific antigen reduces prostate cancer mortality at 15-year follow-up.
Source: JAMA - Journal of the American Medical Association - Category: General Medicine Source Type: research
More News: American Medical Association (AMA) | Cancer | Cancer & Oncology | Clinical Trials | General Medicine | Prostate Cancer